💉 Cosmetic Injectable Complication Vascular Occlusion Simulator

Danger Zones — Where Filler Meets Facial Arteries

Placeholder: fillers sit near named arteries in a few risky facial zones.

• 5: Common danger zones (glabella, nose, lips, temple, sulcus)
• Angular artery: Key vessel (runs beside the nasal sidewall)
• Supraperiosteal: Injection depth risk (safer plane, still not zero risk)
• ~0.001%: Occlusion incidence (rare but serious per injection)

Facial vascular anatomy overview

Placeholder text: arteries cluster around eyes, nose, glabella, and mouth.

Why these zones are risky

Placeholder text: shallow arteries, limited collateral flow, small caliber.

Accidental Intravascular Injection or Vessel Compression

Placeholder: filler enters the lumen or compresses the vessel from outside.

• 2: Mechanisms (direct injection or external compression)
• High pressure: Retrograde flow risk (can push filler toward the eye)
• Seconds–minutes: Onset of symptoms (pain often disproportionate)
• Imperfect: Aspiration reliability (negative aspiration does not exclude risk)

How occlusion happens

Placeholder text: bolus enters artery or squeezes it against bone.

Immediate physical signs

Placeholder text: blanching, severe pain, delayed capillary refill.

Downstream Tissue Ischemia — The Warning Window

Placeholder: blocked flow starves downstream skin, and time is critical.

• Immediate: Blanching onset (skin turns visibly pale white)
• ~1–4 h: Mottling onset (dusky reticulated pattern appears)
• Severe: Pain character (out of proportion to injection)
• Rises with time: Irreversible injury risk (necrosis window narrows fast)

Recognizing the ischemic cascade

Placeholder text: pallor, mottling, dusky color change over hours.

Periocular vision risk

Placeholder text: retinal artery involvement threatens sudden vision loss.

Placeholder highlight: vision-threatening occlusion needs emergency action within minutes.

Hyaluronidase — Dissolving the Occluding Filler

Placeholder: enzyme injections break down hyaluronic acid filler quickly.

• Hyaluronidase: Enzyme (degrades hyaluronic acid filler)
• Repeat, pulsed: High-dose protocol (every 60–90 minutes if needed)
• Minutes: Onset of relief (flow can return quickly)
• Rare: Allergy risk (test dose sometimes considered)

Emergency protocol steps

Placeholder text: recognize, inject hyaluronidase, massage, monitor, repeat.

Why speed matters most

Placeholder text: earlier reversal preserves far more viable tissue.

Rapid Reversal vs. Delayed Recognition

Placeholder: quick treatment saves tissue; delay risks lasting damage.

• ~4–6 h: Golden window (best odds for full recovery)
• Minutes: Vision-risk window (periocular cases are far shorter)
• Rises sharply: Necrosis risk (beyond the golden window)
• Likely if fast: Full recovery (with prompt hyaluronidase treatment)

Successful salvage outcome

Placeholder text: flow restored, tissue color and function return.

Delayed recognition outcome

Placeholder text: prolonged ischemia can cause permanent tissue necrosis.

Placeholder highlight: every minute of delay narrows the salvage window.